AstraZeneca Vaccine: Answers to Questions

Administration information for AstraZeneca COVID-19 Vaccine

13 January 2021Information on batch specific dosing and withdrawing an additional dose from an individual vaccine vial is given.

Dosing information for AstraZeneca COVID-19 Vaccine

13 January 2021Information on intervals between dosing and completion of the vaccination schedule with an alternative brand of vaccine is given.

AstraZeneca COVID-19 Vaccine Formulation information

11 January 2021Formulation information such as latex content, diluent, sodium content and stability, is provided for AstraZeneca COVID-19 Vaccine.

Advising individuals with allergies on their suitability for AstraZeneca COVID-19 Vaccine

8 January 2021Advice on whether people with a previous allergic reaction can have the AstraZeneca COVID-19 vaccine.

Interactions information for AstraZeneca COVID-19 Vaccine

8 January 2021This page summarises and signposts to information about interactions with the AstraZeneca COVID-19 vaccine.

Contraindications and cautions summary for AstraZeneca COVID-19 Vaccine

7 January 2021Specific information for AstraZeneca and signposting to general guidance on contraindications and cautions information common to all COVID-19 vaccines

Excipients information for AstraZeneca COVID-19 Vaccine

7 January 2021This page summarises and signposts to publicly available information from professional and government bodies relating to the AstraZeneca COVID-19 vaccine